Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Nextech3D.ai Reports Strong 20% Q2 Sequential Revenue Growth With Gross Margins of 88% For the Three Months Ended September 30, 2025 ("Q2 2026")
Troy Minerals Updates on the Operational Mining Permit for its Tsagaan Zalaa Silica Project, Mongolia and Initiates Commodity Off-Take Discussions
